Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2022-05-31
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
NCT02887781
Laboratory and Clinical Data in Antiphospholipid Patients
NCT04308564
Primary Lymphedema and Mutation CELSR1 (Cadherin EGF LAG Seven-pass G-type Receptor 1)
NCT04919655
Angelman Syndrome (AS) Biomarker Study
NCT04103333
Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis
NCT00822250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patientes with lymphangioleiomyomatosis
no intervention administered. Recruitment in pneumology department
24h urine
Urine samples will be collected at home over 24 hours
urine sample
A urine sample of 20cc will be collected
Patientes with tuberous sclerosis complex without Lymphangioleiomyomatosis
no intervention administered. Recruitment in neurology department
24h urine
Urine samples will be collected at home over 24 hours
urine sample
A urine sample of 20cc will be collected
Healthy women volunteers
no intervention administered. Recruitment in clinical investigation centre
24h urine
Urine samples will be collected at home over 24 hours
urine sample
A urine sample of 20cc will be collected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
24h urine
Urine samples will be collected at home over 24 hours
urine sample
A urine sample of 20cc will be collected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female carrier of lymphangioleiomyomatosis according to ERS criteria
* Age ≥ 18 years
* Women with no history of lymphangioleiomyomatosis, pulmonary, renal or osteoporotic disease
* Age ≥ 18 years
* Woman followed for tuberous sclerosis complex for whom a chest CT scan less than 3 years old does not objectify a pulmonary cyst. (= without lymphangioleiomyomatosis)
* Woman under judicial protection
* Woman with a urinary tract infection within 15 days
* Person who objected to the data processing
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvain MARCHAND-ADAM
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Tours
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR220020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.